LEVAQUIN Safety Questions, LEVAQUIN Answers


More Here>>Side Effects - FDA Reports 2006-2008

Medications A-Z:   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Welcome! Patientsville.com provides unique information about LEVAQUIN. Our extensive database of LEVAQUIN adverse events and LEVAQUIN warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.

>> Announcements
Check out our Hospital and Home Care Quality Reports.

Ask Our Health Experts about LEVAQUIN

Do You Have a Question about Your Health?

Our Doctors and Nurses will Help You Understand Your Symptoms and Feel Better!
Private, Confidential and Discreet




LEVAQUIN Safety Reports

Total LEVAQUIN reports: 866.
LEVAQUIN FDA safety alerts: No.
Reported deaths: 33    Reported hospitalizations: 178.
Take LEVAQUIN Side Effects Survey or Share Your LEVAQUIN Story. LEVAQUIN Usage.

< Previous  Showing 151-225 of 866 Next >

Consumer or non-health professional from UNITED STATES reported LEVAQUIN problem on Jan 24, 2006. Female patient, 44 years of age, weighting 121.3 lb, was diagnosed with pneumonia and was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: dyspnoea, palpitations. LEVAQUIN dosage: unknown. Patient recovered.

LEVAQUIN problem was reported by a Physician from UNITED STATES on Mar 20, 2006. Female patient, 54 years of age, weighting 124.0 lb, was diagnosed with sinusitis and was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: dysstasia, pain, tendon rupture. LEVAQUIN dosage: 500 MG, 1 IN 1 DAY, ORAL. During the same period patient was treated with KYTRIL, ZELNORM, LUNESTA. Patient recovered.

Physician from UNITED STATES reported LEVAQUIN problem on Jan 30, 2006. Male patient, 42 years of age, weighting 155.0 lb, was diagnosed with vasectomy and was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: aplastic anaemia, pneumococcal sepsis. LEVAQUIN dosage: 500 MG, 1 IN 1 DAY, ORAL. Patient was hospitalized. Patient recovered.

LEVAQUIN problem was reported by a Physician from UNITED STATES on Jan 30, 2006. Female patient, 65 years of age, weighting 154.0 lb, was diagnosed with sinusitis and was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: arthralgia, pain. LEVAQUIN dosage: 500 MG, 1 IN 1 DAY, ORAL. During the same period patient was treated with MOTRIN. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LEVAQUIN problem on Nov 29, 2005. Male patient, 87 years of age, was diagnosed with sinusitis and was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: heart rate increased. LEVAQUIN dosage: unknown. During the same period patient was treated with CARDIAZEM. Patient recovered.

LEVAQUIN problem was reported by a Physician from UNITED STATES on Aug 16, 2006. Male patient was diagnosed with sinusitis and was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: tendon rupture. LEVAQUIN dosage: 500 MG, IN 1 DAY. Patient recovered.

Physician from UNITED STATES reported LEVAQUIN problem on Aug 03, 2006. Male patient, 41 years of age, was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: arthritis. LEVAQUIN dosage: unknown. Patient recovered.

LEVAQUIN problem was reported by a Physician from UNITED STATES on Aug 03, 2006. Male patient, 57 years of age, was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: arthritis. LEVAQUIN dosage: unknown. Patient recovered.

Physician from UNITED STATES reported LEVAQUIN problem on Aug 08, 2006. Female patient was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: hepatic failure. LEVAQUIN dosage: 500 MG, 1 IN 1 DAY. Patient recovered.

LEVAQUIN problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 07, 2006. Male patient, 90 years of age, was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: pneumonia, sepsis. LEVAQUIN dosage: unknown. Patient was hospitalized. Patient died on 07/31/2006.

Consumer or non-health professional from UNITED STATES reported LEVAQUIN problem on Aug 07, 2006. Male patient, 61 years of age, weighting 240.0 lb, was diagnosed with prostatitis and was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: tendon rupture, tendonitis. LEVAQUIN dosage: unknown. During the same period patient was treated with COZAAR, HYTRIN, ALTACE, LIPITOR, ZETA, ASPIRIN, ADVAIR. Patient recovered.

LEVAQUIN problem was reported by a Physician from UNITED STATES on Apr 03, 2006. Female patient, 64 years of age, weighting 94.00 lb, was diagnosed with sinusitis and was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: tendonitis. LEVAQUIN dosage: 750 MG, 1 IN 1 DAY, ORAL. During the same period patient was treated with ASPIRIN, ATENOLOL, CALCIUM, PREMARIN, LISINOPRIL, OMEGA, ACTONEL, ZOLOFT. Patient recovered.

Physician from UNITED STATES reported LEVAQUIN problem on Feb 08, 2006. Female patient was diagnosed with upper respiratory tract infection and was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: cholelithiasis. LEVAQUIN dosage: unknown. Patient recovered.

LEVAQUIN problem was reported by a Physician from UNITED STATES on Mar 22, 2006. Female patient, 74 years of age, weighting 126.0 lb, was diagnosed with influenza and was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: abnormal dreams, hallucination. LEVAQUIN dosage: 500 MG, 1 IN 1 DAY. Patient recovered.

Physician from UNITED STATES reported LEVAQUIN problem on Mar 23, 2006. Male patient, 52 years of age, weighting 175.0 lb, was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: neuropathy. LEVAQUIN dosage: unknown. Patient recovered.

LEVAQUIN problem was reported by a Physician from UNITED STATES on Jan 20, 2006. Female patient, 37 years of age, was diagnosed with sinusitis and was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: convulsion. LEVAQUIN dosage: 750 MG, 1 IN 1 DAY, ORAL. Patient recovered.

Pharmacist from UNITED STATES reported LEVAQUIN problem on Apr 18, 2006. Female patient, 52 years of age, weighting 108.2 lb, was diagnosed with pneumonia and was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: hepatic enzyme increased. LEVAQUIN dosage: 500 MG, 1 IN 1 DAY, ORAL. During the same period patient was treated with PHENOBARBITAL, CARBAMAZEPINE, MEDROXYPROGESTERONE, DILANTIN, ESTROGEN. Patient recovered.

LEVAQUIN problem was reported by a Physician from UNITED STATES on Jan 06, 2006. Female patient, 49 years of age, weighting 167.0 lb, was diagnosed with pneumonia and was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: dizziness, hypoaesthesia, oedema peripheral, pain in extremity, pharyngeal oedema. LEVAQUIN dosage: 500 MG, 1 IN 1 DAY, ORAL. During the same period patient was treated with CONCERTA, CELEXA, ADVAIR, FLONASE, ALBUTEROL. Patient recovered.

Pharmacist from UNITED STATES reported LEVAQUIN problem on Mar 01, 2006. Male patient was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: convulsion. LEVAQUIN dosage: 500 MG, 2 IN 1 DAY, ORAL. Patient recovered.

LEVAQUIN problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 09, 2006. Female patient, 64 years of age, weighting 153.0 lb, was diagnosed with ulcer and was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: joint range of motion decreased, musculoskeletal pain. LEVAQUIN dosage: 500 MG, 1 IN 1 DAY, ORAL. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LEVAQUIN problem on Mar 06, 2007. Male patient, weighting 230.0 lb, was diagnosed with urinary tract infection and was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: neuralgia. LEVAQUIN dosage: 1/500 MG TWICE A DAY PO. Patient recovered.

LEVAQUIN problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 09, 2006. Male patient, 65 years of age, weighting 195.0 lb, was diagnosed with lower respiratory tract infection and was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: blood blister, neuropathy, oedema peripheral, rash macular, weight decreased. LEVAQUIN dosage: 500 MG, 1 IN 1 DAY, ORAL. Patient recovered.

Physician from UNITED STATES reported LEVAQUIN problem on Jan 16, 2006. Female patient, 50 years of age, was diagnosed with streptococcal infection and was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: swollen tongue. LEVAQUIN dosage: 500 MG, 1 IN 1 DAY, ORAL. Patient was hospitalized. Patient recovered.

LEVAQUIN problem was reported by a Physician from UNITED STATES on Mar 22, 2006. Female patient, 21 years of age, weighting 110.0 lb, was diagnosed with upper respiratory tract infection and was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: anaphylactic reaction, myalgia, urticaria. LEVAQUIN dosage: 500 MG, 1 IN 1 DAY, ORAL. Patient recovered.

Physician from UNITED STATES reported LEVAQUIN problem on Feb 15, 2006. Male patient, 51 years of age, weighting 180.0 lb, was diagnosed with prostatitis and was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: neuropathy. LEVAQUIN dosage: 500 MG, 1 IN 1 DAY, ORAL. Patient recovered.

LEVAQUIN problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 31, 2006. Female patient, 80 years of age, was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: tendon rupture. LEVAQUIN dosage: unknown. Patient recovered.

Physician from UNITED STATES reported LEVAQUIN problem on Mar 23, 2006. Male patient, 49 years of age, weighting 224.0 lb, was diagnosed with diverticulitis, gastrointestinal infection and was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: anaphylactic shock. LEVAQUIN dosage: unknown. During the same period patient was treated with FLAGYL. Patient recovered.

LEVAQUIN problem was reported by a Physician from UNITED STATES on Mar 16, 2006. Female patient, 37 years of age, weighting 140.0 lb, was diagnosed with skin infection and was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: herpes zoster, pharyngeal oedema. LEVAQUIN dosage: 500 MG, 1 IN 1 DAY, ORAL. Patient recovered.

Physician from UNITED STATES reported LEVAQUIN problem on June 02, 2006. Male patient, 90 years of age, weighting 231.0 lb, was diagnosed with bronchitis and was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: tendon rupture. LEVAQUIN dosage: 500 MG, 1 IN 1 DAY. Patient recovered.

LEVAQUIN problem was reported by a Physician from UNITED STATES on Mar 06, 2007. Female patient, 41 years of age, weighting 138.0 lb, was diagnosed with sinusitis and was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: arthralgia, neck pain, pain in extremity, plantar fasciitis. LEVAQUIN dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LEVAQUIN problem on Feb 10, 2006. Female patient, 92 years of age, weighting 122.0 lb, was diagnosed with pharyngolaryngeal pain and was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: blood pressure increased, dizziness, heart rate increased. LEVAQUIN dosage: 500 MG, 1 IN 1 DAY, ORAL. Patient recovered.

LEVAQUIN problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 10, 2006. Female patient, 52 years of age, was diagnosed with urinary tract infection and was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: anaphylactic reaction. LEVAQUIN dosage: unknown. Patient recovered.

Physician from UNITED STATES reported LEVAQUIN problem on Mar 13, 2006. Female patient, 60 years of age, weighting 230.0 lb, was diagnosed with gastroenteritis and was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: anaphylactic shock, chest pain. LEVAQUIN dosage: 750 MG, ORAL. Patient was hospitalized. Patient recovered.

LEVAQUIN problem was reported by a Physician from UNITED STATES on Feb 08, 2006. Female patient was diagnosed with upper respiratory tract infection and was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: cholelithiasis. LEVAQUIN dosage: unknown. Patient recovered.

Physician from UNITED STATES reported LEVAQUIN problem on Jan 31, 2006. Male patient, 79 years of age, was diagnosed with pneumonia and was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: tendon disorder, tendon rupture. LEVAQUIN dosage: 500 MG, 1 IN 1 DAY. During the same period patient was treated with COUMADIN. Patient recovered.

LEVAQUIN problem was reported by a Physician from UNITED STATES on Aug 08, 2006. Male patient was diagnosed with pneumonia and was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: crystal urine present, electrolyte imbalance, hypertension, hyponatraemia, weight decreased. LEVAQUIN dosage: 750 MG, 1 IN 1 DAY, ORAL. Patient recovered.

Physician from UNITED STATES reported LEVAQUIN problem on Aug 04, 2006. Male patient, 40 years of age, was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: tendon rupture. LEVAQUIN dosage: unknown. Patient recovered.

LEVAQUIN problem was reported by a Physician from UNITED STATES on Jan 17, 2006. Male patient, 75 years of age, was diagnosed with bronchitis, urinary tract infection and was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: tendon rupture. LEVAQUIN dosage: unknown. Patient recovered.

Physician from UNITED STATES reported LEVAQUIN problem on Aug 08, 2006. Female patient was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: hepatic failure. LEVAQUIN dosage: 500 MG, 1 IN 1 DAY, ORAL. Patient recovered.

LEVAQUIN problem was reported by a Physician from UNITED STATES on Apr 04, 2006. Female patient, 53 years of age, weighting 190.0 lb, was diagnosed with sinusitis and was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: hyperglycaemia, joint effusion, muscle spasms, muscular weakness, paraesthesia, rheumatoid factor. LEVAQUIN dosage: 500 MG, 1 IN 1 DAY, ORAL. During the same period patient was treated with TOPROL, MAGNESIUM, CALCIUM, FOLIC ACID, LISINOPRIL. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LEVAQUIN problem on Sept 26, 2006. Female patient, 57 years of age, weighting 150.0 lb, was diagnosed with sinusitis and was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: arthralgia, muscular weakness, paraesthesia. LEVAQUIN dosage: 500 MG, 1 IN 1 DAY, ORAL. During the same period patient was treated with LEXAPRO, ATENOLOL, PLAVIX, PRAVACHOL, AMBIEN. Patient recovered.

LEVAQUIN problem was reported by a Physician from UNITED STATES on Jan 24, 2006. Female patient, 58 years of age, weighting 134.5 lb, was diagnosed with respiratory tract infection and was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: agitation, chest pain, insomnia, palpitations. LEVAQUIN dosage: 500 MG. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LEVAQUIN problem on Dec 22, 2005. Female patient, 69 years of age, weighting 70.00 lb, was diagnosed with pneumonia and was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: tendon rupture. LEVAQUIN dosage: unknown. During the same period patient was treated with PREDNISONE. Patient was hospitalized and became disabled. Patient recovered.

LEVAQUIN problem was reported by a Physician from UNITED STATES on Sept 11, 2006. Male patient, 66 years of age, was diagnosed with diabetic foot infection and was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: liver function test abnormal, nausea, urticaria, vomiting. LEVAQUIN dosage: 500 MG, IN 1 DAY, ORAL. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported LEVAQUIN problem on Aug 11, 2006. Female patient was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: hepatic failure. LEVAQUIN dosage: unknown. Patient recovered.

LEVAQUIN problem was reported by a Health Professional from UNITED STATES on Dec 29, 2005. Male patient, 62 years of age, weighting 190.0 lb, was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: cough, local swelling, pulmonary mycosis, sinusitis fungal. LEVAQUIN dosage: unknown. During the same period patient was treated with WALGREEN, FLOMAX, AVODART, PREVACID, RELAFEN, OXYCODONE, URECHOLINE. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported LEVAQUIN problem on Apr 03, 2006. Male patient, 81 years of age, weighting 202.0 lb, was diagnosed with epididymitis, urinary tract infection and was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: insomnia, musculoskeletal pain, pain in extremity, tendon rupture. LEVAQUIN dosage: 750 MG, 1 IN 1 DAY, ORAL. During the same period patient was treated with ACIPHEX, PLAVIX, HCTC. Patient recovered.

LEVAQUIN problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 05, 2006. Female patient, 61 years of age, was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: sepsis, stevens-johnson syndrome. LEVAQUIN dosage: 750 MG, ORAL. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported LEVAQUIN problem on Nov 30, 2005. Female patient was diagnosed with upper respiratory tract infection and was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: anaphylactic reaction, rash, urticaria. LEVAQUIN dosage: 500 MG, ORAL. Patient recovered.

LEVAQUIN problem was reported by a Physician from UNITED STATES on Aug 17, 2006. Male patient, 35 years of age, was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: multi-organ failure, urinary retention. LEVAQUIN dosage: 500 MG, IN 1 DAY. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LEVAQUIN problem on Dec 21, 2005. Female patient, 29 years of age, weighting 119.0 lb, was diagnosed with sinusitis and was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: rash, swelling face, throat tightness. LEVAQUIN dosage: 500 MG, 1 IN 1 DAY. Patient recovered.

LEVAQUIN problem was reported by a Physician from UNITED STATES on Aug 10, 2006. Male patient was diagnosed with sinusitis and was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: arthralgia. LEVAQUIN dosage: 750 MG, 1 IN 1 DAY, ORAL. Patient recovered.

Physician from UNITED STATES reported LEVAQUIN problem on Nov 14, 2005. Female patient, 70 years of age, was diagnosed with diverticulitis and was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: abdominal pain, diarrhoea, influenza like illness, serum sickness. LEVAQUIN dosage: 500 MG, 1 IN 1 DAY, ORAL. Patient recovered.

LEVAQUIN problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 15, 2005. Female patient, 68 years of age, was diagnosed with sinusitis and was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: pain. LEVAQUIN dosage: unknown. During the same period patient was treated with NASAL SPRAY NOS. Patient recovered.

Physician from UNITED STATES reported LEVAQUIN problem on Nov 01, 2005. Female patient was diagnosed with sinusitis and was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: tendon rupture. LEVAQUIN dosage: 500 MG, 1 IN 1 DAY, ORAL. Patient recovered.

LEVAQUIN problem was reported by a Physician from UNITED STATES on Dec 13, 2005. Female patient, 50 years of age, weighting 148.0 lb, was diagnosed with urinary tract infection and was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: dyspnoea, rash, urticaria. LEVAQUIN dosage: 500 MG, 1 IN 1 DAY, ORAL. During the same period patient was treated with BACTRIM. Patient recovered.

Pharmacist from UNITED STATES reported LEVAQUIN problem on Nov 16, 2005. Male patient, 64 years of age, was diagnosed with antibiotic prophylaxis and was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: stevens-johnson syndrome. LEVAQUIN dosage: unknown. During the same period patient was treated with FOLIC ACID, VITAMN B, FUROSEMIDE, POTASSIUM, UBIDECARENONE, DIGOXIN. Patient was hospitalized. Patient recovered.

LEVAQUIN problem was reported by a Physician from UNITED STATES on Oct 28, 2005. Female patient, 20 years of age, was diagnosed with sinusitis and was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: anaphylactic reaction. LEVAQUIN dosage: 500 MG, 1 IN 1 DAY. During the same period patient was treated with GUAIFENESIN. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported LEVAQUIN problem on Nov 17, 2005. Female patient, 66 years of age, was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: neuropathy peripheral. LEVAQUIN dosage: unknown. Patient was hospitalized. Patient recovered.

LEVAQUIN problem was reported by a Pharmacist from UNITED STATES on Oct 27, 2005. Male patient, 70 years of age, was diagnosed with cellulitis and was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: bradycardia, cardiac arrest, convulsion. LEVAQUIN dosage: 750 MG, ORAL 500 MG, 1 IN 1 DAY, ORAL. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported LEVAQUIN problem on Nov 09, 2005. Male patient, 80 years of age, was diagnosed with sinusitis, atrial fibrillation and was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: haematoma, international normalised ratio. LEVAQUIN dosage: unknown. During the same period patient was treated with COUMADIN, TOPROL, LASIX, VASOTEC, DIGOXIN. Patient recovered.

LEVAQUIN problem was reported by a Physician from UNITED STATES on Nov 17, 2005. Female patient was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: hypoaesthesia, paraesthesia. LEVAQUIN dosage: unknown. Patient recovered.

Physician from UNITED STATES reported LEVAQUIN problem on July 13, 2006. Male patient, 55 years of age, was diagnosed with prostatitis and was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: tendon rupture. LEVAQUIN dosage: 500 MG, 1 IN 1 DAY, ORAL. Patient recovered.

LEVAQUIN problem was reported by a Physician from UNITED STATES on Jan 18, 2006. Male patient, 42 years of age, weighting 190.0 lb, was diagnosed with prostatitis and was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: tendon rupture. LEVAQUIN dosage: 500 MG, 1 IN 1 DAY, ORAL. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LEVAQUIN problem on July 13, 2006. Female patient was diagnosed with respiratory tract infection and was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: arthralgia, tendon rupture. LEVAQUIN dosage: 250 MG, 1 IN 1 DAY, ORAL. Patient recovered.

LEVAQUIN problem was reported by a Pharmacist from UNITED STATES on Nov 04, 2005. Male patient, 83 years of age, was diagnosed with pneumonia and was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: tendon rupture, tendonitis. LEVAQUIN dosage: unknown. During the same period patient was treated with LIPITOR, TOPROL. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported LEVAQUIN problem on July 05, 2006. Male patient, 95 years of age, was diagnosed with pneumonia and was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: hallucination. LEVAQUIN dosage: 500 MG, 1 IN 1 DAY, ORAL. Patient recovered.

LEVAQUIN problem was reported by a Physician from UNITED STATES on Mar 13, 2006. Male patient, 73 years of age, weighting 185.0 lb, was diagnosed with tuberculosis and was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: feeling cold, nausea, pyrexia, tremor, vomiting. LEVAQUIN dosage: 750 MG, 1 IN 1 DAY, ORAL. During the same period patient was treated with RIFAMATE, PYRAZINAMIDE, VITAMIN B6. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported LEVAQUIN problem on July 21, 2006. Female patient, 31 years of age, weighting 199.0 lb, was diagnosed with acute sinusitis and was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: neuropathy peripheral. LEVAQUIN dosage: 500 MG, 1 IN 1 DAY, ORAL. During the same period patient was treated with FLONASE, ALLEGRA. Patient recovered.

LEVAQUIN problem was reported by a Physician from UNITED STATES on June 30, 2006. Female patient, 82 years of age, was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: tendon rupture. LEVAQUIN dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LEVAQUIN problem on Nov 08, 2005. Female patient, 49 years of age, weighting 116.0 lb, was diagnosed with influenza, pneumonia and was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: arthralgia, weight decreased. LEVAQUIN dosage: unknown. Patient was hospitalized. Patient recovered.

LEVAQUIN problem was reported by a Physician from UNITED STATES on Nov 30, 2005. Female patient, 54 years of age, was diagnosed with urinary tract infection and was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: haemolytic anaemia. LEVAQUIN dosage: 250 MG, 1 IN 1 DAY. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported LEVAQUIN problem on Dec 05, 2005. Female patient, 27 years of age, was diagnosed with chronic sinusitis and was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: angioedema, urticaria. LEVAQUIN dosage: 500 MG, 1 IN 1 DAY. During the same period patient was treated with ADVAIR, CLARITIN, PREDNISONE. Patient recovered.

LEVAQUIN problem was reported by a Physician from UNITED STATES on Nov 11, 2005. Male patient, 62 years of age, was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: anaphylactic reaction. LEVAQUIN dosage: 500 MG, 1 IN 1 DAY, ORAL. During the same period patient was treated with PREMODIAN. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LEVAQUIN problem on Sept 27, 2006. Female patient, 74 years of age, weighting 128.0 lb, was diagnosed with pharyngitis, sinusitis and was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: tendonitis, weight decreased. LEVAQUIN dosage: 750 MG, IN 1 DAY. Patient recovered.

< Previous  Showing 151-225 of 866 Next >

Ask Our Patient Community about LEVAQUIN

Select a Medication and Click to Access Reports about Side Effects and Adverse Reactions

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

This drug has as active FDA Safety Alert This drug has an active FDA Safety Alert
A
Abacavir sulfate
Abatacept
Abilify
Acamprosate calcium
AccuprilThis drug has as active FDA Safety Alert
AccutaneThis drug has as active FDA Safety Alert
AceonThis drug has as active FDA Safety Alert
Aciphex
Actiq (fentanyl citrate)
ActimmuneThis drug has as active FDA Safety Alert
(aripiprazole) (quinapril) (isotretinoin) (perindopril) (rabeprazole) (interferon gamma-1b)
ActonelThis drug has as active FDA Safety Alert (risedronate)
Actoplus MetThis drug has as active FDA Safety Alert (pioglitazone)
ActosThis drug has as active FDA Safety Alert (pioglitazone)
AcuTect (technetium Tc 99m apcitide)
Adefovir dipivoxil
Advair Diskus(Fluticasone propionate; Salmeterol xinafoate)
AdderallThis drug has as active FDA Safety Alert (amphetamine salts)
Agenerase (amprenavir)
Aggrastat (tirofiban)
Alamast (pemirolast)
AlendronateThis drug has as active FDA Safety Alert
AlemtuzumabThis drug has as active FDA Safety Alert
AleveThis drug has as active FDA Safety Alert (naproxen sodium)
Alfuzosin
Alinia (nitazoxanide)
Alimta (pemetrexed)
Alitretinoin
Almotriptan malateThis drug has as active FDA Safety Alert
Alosetron hydrochloride
Aloxi (palonosetron)
Alrex (loteprednol etabonate)
AltaceThis drug has as active FDA Safety Alert (ramipril)
Ambien (zolpidem tartrate)
AmergeThis drug has as active FDA Safety Alert (naratriptan)
Aminolevulinic acid
AmiodaroneThis drug has as active FDA Safety Alert
Amitiza (lubiprostone)
AmnesteemThis drug has as active FDA Safety Alert (isotretinoin)
Amphadase (hyaluronidase)
luronidase)
Amphetamine saltsThis drug has as active FDA Safety Alert
Amprenavir
AnaproxThis drug has as active FDA Safety Alert (naproxen sodium)
Angiomax (bivalirudin)
Anidulafungin
Antagon (ganirelix acetate)
Anthelios SX (avobenzone, ecamsule, octocrylene)
Apidra (insulin glulisine recombinant)
Apokyn (apomorphine)
Aprepitant
Aprotinin
Aptivus (tipranavir)
AranespThis drug has as active FDA Safety Alert (darbepoetin alpha)
Arava (leflunomide)
Arformoterol

Argatroban
ArediaThis drug has as active FDA Safety Alert (pamidronate)
Aripiprazole
Arixtra (fondaparinux)
Aromasin (exemestane)
Arranon (nelarabine)
Arsenic trioxide
Aspirin
Atacand (candesartan cilexetil)
Atazanavir sulfate
AtomoxetineThis drug has as active FDA Safety Alert
Avastin (bevacizumab)
Avelox (moxifloxacin)
Avobenzone, Ecamsule, Octocrylene
Avodart (dutasteride)
Avonex (interferon beta-1a)
AxertThis drug has as active FDA Safety Alert (almotriptan malate)
Azacitidine
Azilect (rasagiline)
Azopt (brinzolamide)

back to top

B
Balsalazide disodium
Baraclude (entecavir)
BenazeprilThis drug has as active FDA Safety Alert
Benicar (olmesartan medoxomil)
Bevacizumab
Bexarotene
BextraThis drug has as active FDA Safety Alert (valdecoxib)
BiaxinThis drug has as active FDA Safety Alert (clarithromycin)
Bimatoprost
Bivalirudin
BonivaThis drug has as active FDA Safety Alert (ibandronate)
Bortezomib
Brinzolamide
Brovana (arformoterol)
BupropionThis drug has as active FDA Safety Alert
Butisol sodium
Byetta (exenatide)


back to top

C
Calfactant
CampathThis drug has as active FDA Safety Alert (alemtuzumab)
Campral (acamprosate calcium)
Cancidas (caspofungin)
Candesartan cilexetil
Capecitabine
CapotenThis drug has as active FDA Safety Alert (captopril)
CaptoprilThis drug has as active FDA Safety Alert
CarbamazepineThis drug has as active FDA Safety Alert
CarbatrolThis drug has as active FDA Safety Alert (carbamazepine)
Carbrital (pentobarbital and carbromal)
Caspofungin
Cefditoren pivoxil
CefepimeThis drug has as active FDA Safety Alert
CeftriaxoneThis drug has as active FDA Safety Alert
CelebrexThis drug has as active FDA Safety Alert (celecoxib)
CelecoxibThis drug has as active FDA Safety Alert
CelexaThis drug has as active FDA Safety Alert (citalopram hydrobromide)
Cetrorelix acetate
Cetrotide (cetrorelix acetate)
Cetuximab
Cevimeline
ChantixThis drug has as active FDA Safety Alert (varenicline)
Cialis (tadalafil)
Cilostazol
Cinacalcet
Cirlesonide
CitalopramThis drug has as active FDA Safety Alert
ClaravisThis drug has as active FDA Safety Alert (isotretinoin)
ClarithromycinThis drug has as active FDA Safety Alert
Clarinex (desloratadine)
Clolar (clofarabine)
Clofarabine
Clozapine
Clozaril (clozapine)
CodeineThis drug has as active FDA Safety Alert
Colazal (balsalazide disodium)
Colesevelam
ColistimethateThis drug has as active FDA Safety Alert
Coly-Mycin M (colistimethate)This drug has as active FDA Safety Alert
Comtan (entacapone)
Concerta (methylphenidate)
Conivaptan
CordaroneThis drug has as active FDA Safety Alert (amiodarone)
CrestorThis drug has as active FDA Safety Alert (rosuvastatin calcium)
Cubicin (daptomycin)
Curosurf (poractant alfa)
CylertThis drug has as active FDA Safety Alert (pemoline)
CymbaltaThis drug has as active FDA Safety Alert (duloxetine)
CytotecThis drug has as active FDA Safety Alert (misoprostol)

back to top

D
Dacogen (decitabine)
Dalfopristin
Dalmane (flurazepam)
Daptomycin
Darbepoetin alphaThis drug has as active FDA Safety Alert
Darifenacin
Darunavir
Dasatinib
Daytrana (methylphenidate transdermal)
DDAVPThis drug has as active FDA Safety Alert (desmopressin)
DDAVP Nasal SprayThis drug has as active FDA Safety Alert (demopressin)
DDAVP Rhinal TubeThis drug has as active FDA Safety Alert (desmopressin)
DDVPThis drug has as active FDA Safety Alert (desmopressin
Decitabine
Deferasirox
Definity (perflutren lipid microspheres)
DepaconThis drug has as active FDA Safety Alert (valproate)
DepakeneThis drug has as active FDA Safety Alert (valproate)
DepakoteThis drug has as active FDA Safety Alert (valproate)
Desloratadine
DesmopressinThis drug has as active FDA Safety Alert
Detrol (tolterodine tartrate)
terodine tartrate)
Dexedrine (dextroamphetamine sulfate)
Dexmedetomidine
Dexmethylphenidate HCl
> Dextroamphetamine sulfate
Diastat AcuDialThis drug has as active FDA Safety Alert
Diazepam rectal gelThis drug has as active FDA Safety Alert
DidronelThis drug has as active FDA Safety Alert (etidronate)
DiprivanThis drug has as active FDA Safety Alert (propofol)
Dofetilide
Doral (quazepam)
Doxercalcif
Drospirenone
DuloxetineThis drug has as active FDA Safety Alert
DuragesicThis drug has as active FDA Safety Alert (fentanyl transdermal system)
Dutasteride

back to top

E

Eculizumab
Edetate disodium
Efalizumab
Efavirenz
EffexorThis drug has as active FDA Safety Alert (venlafaxine)
Elestat (epinastine)
EletriptanThis drug has as active FDA Safety Alert
Elidel (pimecrolimus)
Ellence (epirubicin)
Eloxatin (oxaliplatin)
Emend (aprepitant)
Emtricitabine
Emtriva (emtricitabine)
Enablex (darifenacin)
Enalapril / EnalaprilatThis drug has as active FDA Safety Alert
Endrate (edetate disodium)
Enfuvirtide
Entacapone
Entecavir
Epinastine
Epirubicin
Eplerenone
Epoetin alfaThis drug has as active FDA Safety Alert
EpogenThis drug has as active FDA Safety Alert (epoetin alfa)
Eptifibatide
EquetroThis drug has as active FDA Safety Alert (carbamazepine)
Eraxis (anidulafungin)
Erbitux (cetuximab)
Ertaczo (sertaconazole)
EscitalopramThis drug has as active FDA Safety Alert
Estazolam
Eszopiclone
Ethchlorvynol

Ethinyl estradiol
EtidronateThis drug has as active FDA Safety Alert
Evoxac (cevimeline)
Exelon (rivastigmine tartrate)
Exenatide
Exjade (deferasirox)
Exemestane
Extraneal (icodextrin)
Ezetimibe
Ezetimibe/simvastatin

back to top

F
Factive (gemifloxacin mesylate)
Faslodex (fulvestrant)
FelbamateThis drug has as active FDA Safety Alert
FelbatolThis drug has as active FDA Safety Alert (felbamate)
Fentanyl buccal tabletsThis drug has as active FDA Safety Alert
Fentanyl citrate
Fentanyl transdermal systemThis drug has as active FDA Safety Alert
FentoraThis drug has as active FDA Safety Alert (fentanyl buccal tablets)
Ferrlecit (sodium ferric gluconate complex)
Fleet Accu-PrepThis drug has as active FDA Safety Alert (sodium phosphate)
Fleet Phospho-SodaThis drug has as active FDA Safety Alert (sodium phosphate)
FluoxetineThis drug has as active FDA Safety Alert
Flurazepam
Fluticasone propionate
FluvoxamineThis drug has as active FDA Safety Alert
Focalin (dexmethylphenidate)
Focalin XR (dexmethylphenidate)
Fomivirsen
Fondaparinux
Foradil (formoterol fumarate)
Formoterol fumarate
FosamaxThis drug has as active FDA Safety Alert (alendronate)
FosinoprilThis drug has as active FDA Safety Alert
FrovaThis drug has as active FDA Safety Alert (frovatriptan succinate)
Frovatriptan succinateThis drug has as active FDA Safety Alert
Fulvestrant
Fuzeon (enfuvirtide)

G
GabapentinThis drug has as active FDA Safety Alert
GabitrilThis drug has as active FDA Safety Alert (tiagabine)
Gadobenate DimeglumineThis drug has as active FDA Safety Alert
GadodiamideThis drug has as active FDA Safety Alert
GadoliniumThis drug has as active FDA Safety Alert
Gadopentetate DimeglumineThis drug has as active FDA Safety Alert
GadoteridolThis drug has as active FDA Safety Alert
GadoversetamideThis drug has as active FDA Safety Alert
GalantamineThis drug has as active FDA Safety Alert
Ganirelix acetate
GatifloxacinThis drug has as active FDA Safety Alert
GefitinibThis drug has as active FDA Safety Alert
Gemifloxacin mesylate
Gemtuzumab ozogamicin
Geodon (ziprasidone)
Gleevec (imatinib mesylate)

back to top

H
Halcion (triazolam)
HaldolThis drug has as active FDA Safety Alert (haloperidol)
Haloperidol
This drug has as active FDA Safety Alert
Hectorol (doxercalcif)
Hepsera (adefovir dipivoxil)
Hyaluronidase
Hydase (hyaluronidase)
Human Secretin

back to top

I
IbandronateThis drug has as active FDA Safety Alert
Ibuprofen
Icodextrin
Iloprost
Imatinib mesylate
Increlex (Mecasermin [rDNA origin]
Infasurf Preservative Free (calfactant)
ImitrexThis drug has as active FDA Safety Alert (sumatriptan)
Innohep (tinzaparin)
Inspra (eplerenone)
Insulin Aspart recombinant
Insulin Detemir recombinant
Insulin Glargine recombinant

Insulin Glulisine recombinant

Intron A (interferon alfa-2b)
Integrilin (eptifibatide)
ifibatide)
Interferon alfa-2b
Interferon beta-1a
Interferon gamma-1bThis drug has as active FDA Safety Alert
Invega (paliperidone)
Iplex  (mecasermin rinfabate)
IressaThis drug has as active FDA Safety Alert (gefitinib)
IsotretinoinThis drug has as active FDA Safety Alert

back to top

J
Januvia (sitagliptin phosphate)

back to top

K
Kaletra (lopinavir; ritonavir)
Kepivance (palifermin)
KeppraThis drug has as active FDA Safety Alert (levetiracetam)
Ketek (telithromycin)
Ketotifen fumarate

back to top

L
LamictalThis drug has as active FDA Safety Alert (lamotrigine)
LamotrigineThis drug has as active FDA Safety Alert
Lantus (insulin glargine recombinant)
Leflunomide
Lenalidomide
Lepirudin recombinant
Levalbuterol
Levemir (insulin detemir recombinant)
LevetiracetamThis drug has as active FDA Safety Alert
Levitra (vardenafil)
Levonorgestrel
Levothyroxine sodium
Levulan Kerastick (aminolevulinic acid)
LexaproThis drug has as active FDA Safety Alert (escitalopram)
Lindane
Linezolid
This drug has as active FDA Safety Alert
LisinoprilThis drug has as active FDA Safety Alert
Lopinavir/ritonavir
Lotemax (loteprednol etabonate)
LotensinThis drug has as active FDA Safety Alert (benazepril)
Loteprednol etabonate
Lotronex (alosetron hydrochloride)
Lubiprostone
Lucentis (ranibizumab)
Lumigan (bimatoprost)
Lunestra (eszopiclone)
LyricaThis drug has as active FDA Safety Alert (pregabalin)

back to top

M
Macugen (pegaptanib)
MagnevistThis drug has as active FDA Safety Alert (gadopentetate dimeglumine)
Maraviroc
MavikThis drug has as active FDA Safety Alert (trandolapril)
MaxaltThis drug has as active FDA Safety Alert (rizatriptan benzoate)
MaxipimeThis drug has as active FDA Safety Alert (cefepime)
Mecasermin [rDNA origin]
Mecasermin-rinfabate
Meloxicam
Memantine
Metadate CD (methylphenidate HCl)
ylphenidate HCl)
Methylphenidate HCl
Methylphenidate transdermal
Mequinol
Micafungin
Micardis (telmisartan)
misartan)
MifeprexThis drug has as active FDA Safety Alert (mifepristone)
MifepristoneThis drug has as active FDA Safety Alert
Miglustat
MinirinThis drug has as active FDA Safety Alert (desmopressin)
MirtazapineThis drug has as active FDA Safety Alert
MisoprostolThis drug has as active FDA Safety Alert
Mobic (meloxicam)
Modafinil
MoexiprilThis drug has as active FDA Safety Alert
MonoprilThis drug has as active FDA Safety Alert (fosinopril)
Moxifloxacin
MultiHanceThis drug has as active FDA Safety Alert (gadobenate dimeglumine)
Mycamine (micafungin)
Mylotarg (gemtuzumab ozogamicin)

back to top

N
Namenda (memantine)
NaprosynThis drug has as active FDA Safety Alert (naproxen)
NaproxenThis drug has as active FDA Safety Alert
Naratriptan
Nesiritide recombinant
Nateglinide
Natrecor (nesiritide recombinant)
NefazodoneThis drug has as active FDA Safety Alert
Nelarabine
NeoTect Kit (technetium Tc 99m depreotide)
Nesiritide recombinant
NeurontinThis drug has as active FDA Safety Alert (gabapentin)
Nexavar (sorafenib)
Nitazoxanide
Nitisinone
Norelgestromin
NovoLog (insulin aspart recombinant)
Noxafil (posaconazole)

back to top

O
Olanzapine
Olanzapine/fluoxetineThis drug has as active FDA Safety Alert
Olmesartan medoxomil
Omacor (omega-3-acid ethyl esters)
OmalizumabThis drug has as active FDA Safety Alert
Omega-3-acid ethyl esters
Omnaris (cirlesonide)
OmniscanThis drug has as active FDA Safety Alert (gadodiamide)
OptiMARK (gadoversetamide)
Optison (perflutren protein-type A microspheres)
Orencia (abatacept)
Orfadin (nitisinone)
Orlistat
Ortho Evra (norelgestromin; ethinyl estradiol)
Oseltamivir phosphate
OsmoprepThis drug has as active FDA Safety Alert (sodium phosphate)
Oxaliplatin
OxcarbazepineThis drug has as active FDA Safety Alert


back to top

P
PaceroneThis drug has as active FDA Safety Alert (amiodarone)
Palifermin
Paliperidone
PamidronateThis drug has as active FDA Safety Alert
Panitumumab
Panretin Gel (alitretinoin)
Pantoprazole
Paricalcitol
ParoxetineThis drug has as active FDA Safety Alert
PaxilThis drug has as active FDA Safety Alert (paroxetine)
Pegaptanib
Pegvisomant

Pemetrexed
PemolineThis drug has as active FDA Safety Alert
Pentobarbital and carbromal
Perflutren lipid microspheres
PerindoprilThis drug has as active FDA Safety Alert
PhenerganThis drug has as active FDA Safety Alert (promethazine)
Pimecrolimus

PioglitazoneThis drug has as active FDA Safety Alert
Placidyl (ethchlorvynol)
Plan B (levonorgestrel)
Pletal (cilostazol)
Poractant alfa
Posaconazole
Pramlintide Acetate
Precedex (dexmedetomidine)
PregabalinThis drug has as active FDA Safety Alert
Prezista (darunavir)
Prialt (ziconotide)
Priftin (rifapentine)
PrinivilThis drug has as active FDA Safety Alert (lisinopril)
ProcritThis drug has as active FDA Safety Alert (epoetin alfa)
ProHanceThis drug has as active FDA Safety Alert (gadoteridol)
PromethazineThis drug has as active FDA Safety Alert
PropofolThis drug has as active FDA Safety Alert
Prosom (estazolam)
Protonix (pantoprazole)
Protopic (tacrolimus)
Provigil (modafinil)
ProzacThis drug has as active FDA Safety Alert (fluoxetine)
Prussian blue


back to top

Q
Quazepam
Quetiapine

QuinaprilThis drug has as active FDA Safety Alert
Quinupristin

R
Rabeprazole
Radiogardase
(prussian blue)
Ramelteon
RamiprilThis drug has as active FDA Safety Alert
Ranexa (ranolazine)
Ranibizumab
Ranolazine
Rapamune (sirolimus)
Raptiva (efalizumab)
Rasagiline
RazadyneThis drug has as active FDA Safety Alert (galantamine)
Rebetol (ribavirin)
ReclastThis drug has as active FDA Safety Alert (zoledronic acid)
Refludan (lepirudin recombinant)
Relenza (zanamivir)
RelpaxThis drug has as active FDA Safety Alert (eletriptan)
RemeronThis drug has as active FDA Safety Alert (mirtazapine)